Synaptic Transmission in Neurodegeneration

Synaptic alterations are emerging as critical determinants of neurodegeneration. Here is the latest research on alterations of synaptic transmission and plasticity in neurodegeneration and neurodegenerative disorders.

January 21, 2022
Open Access

The synaptic vesicle protein Mover/TPRG1L is associated with lipid droplets in astrocytes

BioRxiv : the Preprint Server for Biology
J. KrohnThomas Dresbach
January 21, 2022

Effect of curcumin nanoparticles on streptozotocin-induced male Wistar rat model of Alzheimer's disease.

Metabolic Brain Disease
Neveen A NoorHaitham S Mohammed
January 21, 2022

Fading memories in aging and neurodegeneration: Is p75 neurotrophin receptor a culprit?

Ageing Research Reviews
Lik-Wei WongSreedharan Sajikumar
January 20, 2022

Influences of glaucoma on the structure and function of synapses in the visual system.

Antioxidants & Redox Signaling
Matthew Van Hook
January 17, 2022
Open Access

Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus.

Frontiers in Cellular Neuroscience
Theresa S RimmelePaul Allen Rosenberg
January 17, 2022

Ganglioside binding domains in proteins: Physiological and pathological mechanisms.

Advances in Protein Chemistry and Structural Biology
Fodil AzzazJacques Fantini
January 14, 2022

Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy.

Brain : a Journal of Neurology
Yu Young JeongQian Cai
January 13, 2022

Optimization of application-driven development of in vitro neuromuscular junction models.

Tissue Engineering. Part B, Reviews
Julie B StricklandEmilia A Solomon
January 12, 2022
Open Access

Systematic Review on Parkinson's Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson's Symptoms.

International Journal of Environmental Research and Public Health
Palanisamy SivanandyPhoon Kok Hong
January 12, 2022
Open Access

Covering the Role of PGC-1α in the Nervous System.

Zuzanna KuczynskaLeonora Buzanska
January 12, 2022
Open Access

LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights.

Patrick D SkeltonLoukia Parisiadou
January 12, 2022

Distribution of Aquaporin-4 channels in hippocampus and prefrontal cortex in mk-801-treated balb/c mice.

Ultrastructural Pathology
Omer Burak EricekDervis Mansuri Yilmaz
January 12, 2022

Neurotrophic factors in Alzheimer's disease: pathogenesis and therapy.

Acta Neurobiologiae Experimentalis
Joachim Hr LübkeAkram Sadeghi
January 12, 2022

DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family.

Brain : a Journal of Neurology
Fubo ChengOlaf Riess
January 11, 2022
Open Access

G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-β in Alzheimer's disease.

Molecular Biomedicine
Smita Eknath DesaleSubashchandrabose Chinnathambi
January 9, 2022

Vasoactive neuropeptides and Alzheimer's disease: a systematic review focusing on calcitonin gene-related peptide.

Journal of Integrative Neuroscience
Giulio PapiriArianna Vignini

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved